Articles

July 28, 2020: Update from Managed Care Payers: COVID-19 Recovery, the Road Ahead

By Michael Kolodziej, MD; Bryan Loy, MD, MBA; Lee N. Newcomer, MD, MHA; Steven Peskin, MD, MBA, FACP; Michael Sherman, MD, MBA, MS; Burt Zweigenhaft, PhD, D.Litt

COVID-19

One of the most significant questions for payers in the COVID-19 health ecosystem is, “Will reimbursement parity for telehealth services continue?” Leading representatives of major managed care organizations debate the prospects.

Oncology Pharmacy Update

COVID-19

Shortages, inventory management, and challenges of in-home care were just a few of the topics in AVBCC’s wide-ranging webinar on how COVID-19 is affecting oncology pharmacy.

Patient Advocacy Update

COVID-19

As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials.

July 22, 2020: Patient Advocacy Update: COVID-19 Recovery, the Road Ahead

By Elizabeth Franklin, LGSW, ACSW; Patricia J Goldsmith; Amy Niles, MBA; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Burt Zweigenhaft, PhD, D.Litt

COVID-19

As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials.

July 21, 2020: Oncology Pharmacy Update: COVID-19 Recovery, the Road Ahead

By Scott Freeswick, MS, PharmD; Niesha Griffith, RPh, MS, FASHP; Chris Marcum, PharmD; Ali McBride, PharmD, MBA; Stacey McCullough, PharmD; Bhavesh Shah, RPh, BCOP; Burt Zweigenhaft, PhD, D.Litt

COVID-19

Shortages, inventory management, and challenges of in-home care were just a few of the topics in AVBCC’s wide-ranging webinar on how COVID-19 is affecting oncology pharmacy.

COVID-19

As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?

COVID-19

The COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks?

July 15, 2020: Oncology Home Infusion in Post-COVID-19 World: COVID-19 Recovery, the Road Ahead

By Roger Brito, DO; Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP, FAAN; Michael Kolodziej, MD; Barbara L. McAneny, MD; Steven Peskin, MD, MBA, FACP; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt

COVID-19

The COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks?

Telehealth & Oncology During the Fight Against COVID-19 and Its Aftermath

By Bellinda Conte; Ann Ford; Femida Gwandry-Sridhar, PhD; Nancy Kaszak; Lisa Mazur; Kenneth Miller, MD; Christina Naso; Vernessa Pollard; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt

This webinar highlights the ways telehealth can provide the vital and essential care demanded within the field of oncology, with a focus on rural health, palliative care, digital therapeutics, clinical trials, home chemotherapy infusion, and more.

July 14, 2020: Potential For Cancer Agents in the Treatment of COVID-19: COVID-19 Recovery, the Road Ahead

By David DeRemer, PharmD, BCOP, FCCP, FHOPA; Michael Joyner, MD; Maurie Markman, MD; Kevin O’Hayer, MD, PhD; Bhavesh Shah, RPh, BCOP; Mark Sloan, MD; Burt Zweigenhaft, PhD, D.Litt

COVID-19

As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?

Top Trending Articles

Stay In The Know

Articles

Page 65 of 329

Top Trending Articles

Stay In The Know